CANCER COMMONS

Mountain View, CA   |  www.cancercommons.org

Mission

Cancer Commons network of cancer patients, physicians, scientists, volunteers, and partners connect and leverage the world's best cancer knowledge and resources to help patients and their physicians make the most informed treatment decisions.

Ruling year info

2012

Executive Director

Erika Vial Monteverdi

Main address

650 Castro St Ste 120-522

Mountain View, CA 94041 USA

Show more contact info

EIN

45-3266802

NTEE code info

Cancer (G30)

Cancer Research (H30)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2019, 2018 and 2017.
Register now

Communication

Blog

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

Advanced cancer patients come to Cancer Commons terrified and overwhelmed. They have exhausted the standard of care and many have failed previous trials. Cancer Commons advances the proposition that for even the most vulnerable patients, longer life expectancy and better quality of life are attainable

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Cancer Commons

By tightly coupling clinical research and customized patient care and by bringing real-world data to the front lines of cancer research, we help advanced cancer patients and their physicians collectively explore the latest and best treatment options far more efficiently than they can as individuals.

Population(s) Served
People with diseases and illnesses
Caregivers

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Number of families served in cancer treatment

This metric is no longer tracked.
Totals By Year
Population(s) Served

Chronically ill people, Terminally ill people, People with other disabilities, People with physical disabilities, Low-income people

Related Program

Cancer Commons

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Context Notes

Our July 2019-June 2020 numbers-served figure was significantly impacted by COVID. In the first quarter of this year we have already served 60% of of last year's number.

Our Sustainable Development Goals

SOURCE: Self-reported by organization

Learn more about Sustainable Development Goals.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

By tightly coupling clinical research and customized patient care and by bringing real-world data to the front lines of cancer research, we help our patients and their physicians collectively explore the latest and best treatment options far more efficiently than they can as individuals.

Long before COVID-19 changed the face of medical care, Cancer Commons built our processes around the existing fragmented healthcare system. We refer patients to our own Virtual Tumor Boards—panels of scientists and experts practicing at elite cancer centers and academic institutions across the nation—who assess patients’ treatment history, clinical, radiological, and molecular information. We then provide patients with a detailed treatment options report that may include clinical trials, promising off-label treatments, and/or expanded-access or compassionate-use treatment programs.

Cancer Commons’ process is faster and more comprehensive than seeking opinions from individual experts and reduces the amount of time required to assess the best options. Cancer Commons Virtual Tumor Boards meet regularly to review patient cases, either synchronously by video conferencing or asynchronously online. For patient data that are completely assembled, a consensus can be reached—
and a report delivered—within a week.

Contrast this with the usual, time-consuming process of seeking individual second (and third) opinions in person. The patient/caregiver must provide medical records to each individual expert; the expert must review medical records, radiology data, and pathology slides then provide responses; patients may be required to travel to another institution, in another state or even cross-country, in order to obtain that opinion or screening for clinical trials. Having to go through all of these steps significantly delays treatment, especially during this pandemic.

Cancer Commons has built and grown strategic collaborations with organizations and experts at the forefront of their specialties to expand our capacity to generate clinically actionable insights and help advanced cancer patients obtain the best possible outcomes while accelerating knowledge acquisition:

• Eric T. Wong, MD, Associate Professor of Neurology at Harvard Medical School, Co-Director of the Brain Tumor Center at Beth Israel Deaconess Medical Center, and a Neuro-Oncology affiliate member of Dana Farber/Harvard Cancer Center joined Cancer Commons as the Medical Director for Brain Cancer.

• Under the direction of Dr. Wong, we established the Brain Cancer Commons Collaboration with the Musella Foundation for Brain Cancer Research to reach more patients and provides information on personalized treatment options to patients with advanced brain cancer who have exhausted standard therapies.

• Shaalan Beg, MD, MSCS, Professor of Hematology and Medical Oncology and Medical Director of the Clinical Research Office at UT Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center, became part of Cancer Commons as the Medical Director for Pancreatic Cancer.

• Under the direction of Dr. Beg, we have engaged in formal partnerships with the Pancreatic Cancer Action Network and Let’s Win! Pancreatic Cancer in preparation to launch a Pancreatic Cancer Perpetual Trial that will complement traditional clinical trials and tightly integrate clinical research and clinical care.

• Cancer Commons patients who would otherwise not have access to tumor molecular profiling will be able to access this critical tool at no cost to them, via our partnership with TEMPUS— a technology company that has built the world's largest library of clinical and molecular data—or PanCAN’s Know Your Tumor program.

• We are increasing outreach and providing potentially life-extending help to more patients with the most dire diagnoses across all cancer types by expanding our partnership with the American Cancer Society, the largest voluntary health organization in the world.

• Cancer Commons sponsored a dedicated patient and advocate track at the 17th annual Precision Medicine World Conference (PMWC) in Silicon Valley. PMWC is the largest and original annual conference dedicated to precision medicine in the world. It featured 400 speakers and engages 2,500+ attendees, including top global researchers and medical professionals and innovators from across healthcare and biotechnology sectors.

• Cancer Commons developed a new website this year that clearly articulates the value of our services to patients and physicians. In addition to the website, we continue to develop patient content and third-party publications to educate patients and physicians about actionable insights.

Our virtual, distributed approach helps many patients receive advanced treatments close to home and ensures researchers can continue to get the data they need to validate novel treatments. Our team provides navigation services, research of personalized treatment options, and Virtual Tumor Board services to give patients a comprehensive plan that includes best treatment options, access to those treatments, and monitoring over time.

Since July 1, 2020 Cancer Commons has already been contacted for help by 60% more patients than we helped all of last fiscal year.

How we listen

SOURCE: Self-reported by organization

Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.

done We shared information about our current feedback practices.
  • How is your organization collecting feedback from the people you serve?

    Electronic surveys (by email, tablet, etc.), Case management notes,

  • How is your organization using feedback from the people you serve?

  • With whom is the organization sharing feedback?

  • What challenges does the organization face when collecting feedback?

Financials

CANCER COMMONS
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

CANCER COMMONS

Board of directors
as of 12/1/2020
SOURCE: Self-reported by organization
Board chair

Jay Marty Tenenbaum

Cancer Commons, CommerceNet, xCures

Laurence Marton, MD

American Association for Cancer Research Foundation

Gladys Monroy, PhD, JD

Morrison Foerster

Edgar Staren, MD, PhD, MBA

Cancer Treatment Centers of America

Vern Norviel

Wilson Sonsini Goodrich & Rosati

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? No
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? No
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? No
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? No
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? No

Organizational demographics

SOURCE: Self-reported; last updated 11/10/2020

Who works and leads organizations that serve our diverse communities? GuideStar partnered on this section with CHANGE Philanthropy and Equity in the Center.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female, Not transgender (cisgender)
Sexual orientation
Heterosexual or Straight
Disability status
Person without a disability

Race & ethnicity

Gender identity

 

Sexual orientation

No data

Disability

No data